C4 Current Issues in Gonorrhea Prevention and Control

Wednesday, March 10, 2010: 10:30 AM-12:15 PM
International Ballroom E/F (M2) (Omni Hotel)
10:45 AM
C4b
Utilizing Geomapping, Reported Gonorrhea Morbidity Information and Screening Venues Data to Target Resources Efficiently
Melinda Salmon, BA, STD Control Program, Philadelphia Department of Public Health, Philadelphia, PA, Greta Anschuetz, MPH, STD Control Program, Philadelphia Department of Public Health, Phialdelphia, PA and Caroline Johnson, MD, Division of Disease Control, Philadelphia Department of Public Health, Philadelphia, PA
11:00 AM
C4c
Increased Detection and Geographic Spread of Gonorrhea, Chlamydia and Syphilis in Boston Area Men Who Have Sex with Men, 1997-2008
Kenneth Mayer, MD, The Fenway Institute, Fenway Health, Boston, MA, Matthew Mimiaga, ScD, MPH, and The Fenway Institute, Harvard Medical School, Boston, MA and Chris Grasso, MPH, The Fenway Institue, Fenway Health, Boston, MA
11:15 AM
C4d
Prescribing Changes Following Revised Treatment Guidelines for Gonorrhea: An Interrupted Time Series Analysis
Deborah Dowell, MD1, Lin H. Tian, MD, MS1, Jeffrey A. Stover, MPH2, Jennifer A. Donnelly, BS3, Summer Martins, MPH4, Emily Erbelding, MD, MPH5, Raul Pino, MD6, Hillard Weinstock, MD, MPH1 and Lori Newman, MD1, 1Division of STD Prevention, CDC, Atlanta, GA, 2Division of Disease Prevention, Virginia Department of Health, Richmond, VA, 3Colorado Department of Public Health and Environment, Denver, CO, 4STD and HIV Section, Minnesota Department of Health, St. Paul, MN, 5Baltimore City Health Department, Baltimore, MD, 6Connecticut Department of Public Health, Hartford, CT
11:30 AM
C4e
The Use of Real-Time PCR to Screen Nesseria Gonorrhoeae Isolates for PenA Alterations San Francisco, 2009
Pennan Barry, MD, MPH1, Mark Pandori, PhD, HCLD(ABB)2, Abel Wu, BS2, Kyle T. Bernstein, PhD, ScM1 and Susan S. Philip, MD, MPH1, 1STD Prevention and Control Services, San Francisco Department of Public Health, San Francisco, CA, 2Public Health Laboratory, San Francisco Department of Public Health, San Francisco, CA
11:45 AM
C4f
Suppose Cephalosporin-Resistant Gonorrhea Has Landed -- Now What Do You Do?
Stuart Berman, MD, ScM1, Tun Ye, MBBS, PhD2, Hillard Weinstock, MD, MPH3, Eileen Yee, MD4, Ron Ballard, PhD2 and Charlotte K. Kent, PhD5, 1Division of STD Prevention, Epidemiology and Surevillance Branch, Centers for Disease Control and Prevention, Atlanta, GA, 2Laboratory Reference and Research Branch, Division of STD Prevention, Centers for Disease Control and Prevention, Atlanta, GA, 3Division of STD Prevention, CDC, Atlanta, GA, 4Division of STD Prevention, Centers for Disease Control and Prevention, Atlanta, GA, 5Division of STD Prevention; Health Services Research and Evaluation Branch, CDC, Atlanta, GA
See more of: Oral and Poster